26 Jun 2025Open access4cites
HIV-1 Drug Resistance in Children and Implications for Pediatric Treatment Strategies: A Systematic Review and Meta-analysisPublisher siteOpen Forum Infectious Diseases, HIV/AIDS drug development and treatment
UniversitiesDavy-Hyacinthe Anguechia Gouissi
Active, last published 2026
In hiv/aids drug development and treatment
Davy-Hyacinthe Anguechia
Gouissi
Scholar“Research focused on HIV/AIDS drug development and treatment and adjacent fields.”
Centre International De Reference Chantal Biya
Claim Your Profile3
H-index
24
Citations
Davy-Hyacinthe has not officially claimed their profile. If you are Davy-Hyacinthe, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
avy-Hyacinthe Anguechia Gouissi is a researcher working on HIV/AIDS drug development and treatment. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Davy-Hyacinthe's work has been cited 24 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
HIV/AIDS drug development and treatment×4HIV/AIDS Research and Interventions×3HIV Research and Treatment×2Renal Transplantation Outcomes and Treatments×1
04 · Where I am
Affiliations
Affiliation on published researchCentre International De Reference Chantal BiyaDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
5 works30 May 2025Open access
Gestion optimisée des intrants pour une réponse efficace en contexte de pandémie au CamerounPublisher siteJournal of Public Health in Africa, COVID-19 epidemiological studies
16 May 2025Open access4cites
Confirmed virological failure following enhanced adherence counseling among virally unsuppressed children and adolescents on dolutegravir-based versus other regimens: Evidence from a cohort analysis in CameroonPublisher siteMedicine, HIV/AIDS drug development and treatment
12 Sept 2024Open access9cites
Evaluation of Viral Suppression in Paediatric Populations: Implications for the Transition to Dolutegravir-Based Regimens in Cameroon: The CIPHER-ADOLA StudyPublisher siteBiomedicines, HIV/AIDS drug development and treatment
5 Jul 2024Open access1cites
Evidence On Viral Suppression Supports Scaling-Up Transition To Dolutegravir-Based Regimens In Pediatric Populations In Cameroon: A Multicentre Baseline Assessment For The Cipher-Adola StudyPublisher sitePreprints.org, HIV/AIDS drug development and treatment
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Davy-Hyacinthe?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you